NMDA receptor encephalitis (NMDAR-E) can be associated with severe dyskinesias and lifethreatening dysautonomia, 1 with the need for an intensive care setting. After NMDAR-E, severe long-term disability is infrequent 2 ; however, its exact basis remains ill-defined.
Discussion
Poor outcome with severe disability or death after NMDAR-E is rare, 2 and the pathophysiologic basis for persistent neurologic impairment remains largely unknown. Nevertheless, there are some risk factors that are represented by our case, including life-threatening dysautonomia resulting in severe blood pressure fluctuations with organ damage and orofacial dyskinesias compromising artificial ventilation 1, 5 with the need for multidrug analgosedation leading to hepatotoxicity. The switch to a volatile anesthetic was a reasonable consequence; however, long-term isoflurane can be associated with a reversible mitochondrial toxicity, 6 apparent by imaging hallmarks, as well as putative CSF markers for mitochondrial dysfunction and neuronal damage, so a balanced analgosedation can be a challenge in NMDAR-E. In long term, our patient developed functional disability in cognitive impairment with partial remission, a severe neuropathy attributed to CIP/CIM after repeated sepsis, and persistent cerebellar atrophy, all of them representing additional risk factors for poor outcome. Reversible cerebellar ataxia is rare in adult NMDAR-E (<3%) 2 and is progressive in only a few patients. 6 As septic encephalopathy spares the cerebellum, cerebellar atrophy omitted the cerebellar nuclei previously involved in isoflurane-associated MRI changes in our case and the 2 patients with ataxia reported in the literature did not receive isoflurane, 6 we hypothesize an alternative yet unknown pathophysiology.
In summary, multiple complications after NMDAR-E represent a rarity, some of which indeed may lead to long-term impairment, e.g., cognitive decline, CIP/CIM, and cerebellar atrophy. Further research is warranted to elucidate the diverse pathophysiologies of chronic severe functional impairment after NMDAR-E.
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